Short interest in Prelude Therapeutics Inc (NASDAQ:PRLD) increased during the last reporting period, rising from 3.26M to 3.38M. This put 19.5% of the company's publicly available shares short.

Short interest for Prelude Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Prelude Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.02M shares traded per day, it would take 3.33 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.